BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19058055)

  • 1. Longitudinal assessment of grey matter contraction in amyotrophic lateral sclerosis: A tensor based morphometry study.
    Agosta F; Gorno-Tempini ML; Pagani E; Sala S; Caputo D; Perini M; Bartolomei I; Fruguglietti ME; Filippi M
    Amyotroph Lateral Scler; 2009 Jun; 10(3):168-74. PubMed ID: 19058055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and functional evaluation of cortical motor areas in Amyotrophic Lateral Sclerosis.
    Cosottini M; Pesaresi I; Piazza S; Diciotti S; Cecchi P; Fabbri S; Carlesi C; Mascalchi M; Siciliano G
    Exp Neurol; 2012 Mar; 234(1):169-80. PubMed ID: 22226599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural MRI correlates of amyotrophic lateral sclerosis progression.
    Senda J; Atsuta N; Watanabe H; Bagarinao E; Imai K; Yokoi D; Riku Y; Masuda M; Nakamura R; Watanabe H; Ito M; Katsuno M; Naganawa S; Sobue G
    J Neurol Neurosurg Psychiatry; 2017 Nov; 88(11):901-907. PubMed ID: 28501822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global brain atrophy and corticospinal tract alterations in ALS, as investigated by voxel-based morphometry of 3-D MRI.
    Kassubek J; Unrath A; Huppertz HJ; Lulé D; Ethofer T; Sperfeld AD; Ludolph AC
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2005 Dec; 6(4):213-20. PubMed ID: 16319024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortical and subcortical grey matter atrophy in Amyotrophic Lateral Sclerosis correlates with measures of disease accumulation independent of disease aggressiveness.
    Dieckmann N; Roediger A; Prell T; Schuster S; Herdick M; Mayer TE; Witte OW; Steinbach R; Grosskreutz J
    Neuroimage Clin; 2022; 36():103162. PubMed ID: 36067613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exposing asymmetric gray matter vulnerability in amyotrophic lateral sclerosis.
    Devine MS; Pannek K; Coulthard A; McCombe PA; Rose SE; Henderson RD
    Neuroimage Clin; 2015; 7():782-7. PubMed ID: 25844330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Widespread sensorimotor and frontal cortical atrophy in Amyotrophic Lateral Sclerosis.
    Grosskreutz J; Kaufmann J; Frädrich J; Dengler R; Heinze HJ; Peschel T
    BMC Neurol; 2006 Apr; 6():17. PubMed ID: 16638121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A voxel-based morphometry study of patterns of brain atrophy in ALS and ALS/FTLD.
    Chang JL; Lomen-Hoerth C; Murphy J; Henry RG; Kramer JH; Miller BL; Gorno-Tempini ML
    Neurology; 2005 Jul; 65(1):75-80. PubMed ID: 16009889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gray matter and white matter changes in non-demented amyotrophic lateral sclerosis patients with or without cognitive impairment: A combined voxel-based morphometry and tract-based spatial statistics whole-brain analysis.
    Christidi F; Karavasilis E; Riederer F; Zalonis I; Ferentinos P; Velonakis G; Xirou S; Rentzos M; Argiropoulos G; Zouvelou V; Zambelis T; Athanasakos A; Toulas P; Vadikolias K; Efstathopoulos E; Kollias S; Karandreas N; Kelekis N; Evdokimidis I
    Brain Imaging Behav; 2018 Apr; 12(2):547-563. PubMed ID: 28425061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal imaging in
    Floeter MK; Bageac D; Danielian LE; Braun LE; Traynor BJ; Kwan JY
    Neuroimage Clin; 2016; 12():1035-1043. PubMed ID: 27995069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Widespread grey matter pathology dominates the longitudinal cerebral MRI and clinical landscape of amyotrophic lateral sclerosis.
    Menke RA; Körner S; Filippini N; Douaud G; Knight S; Talbot K; Turner MR
    Brain; 2014 Sep; 137(Pt 9):2546-55. PubMed ID: 24951638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Grey matter damage in progressive multiple sclerosis versus amyotrophic lateral sclerosis: a voxel-based morphometry MRI study.
    Tavazzi E; Laganà MM; Bergsland N; Tortorella P; Pinardi G; Lunetta C; Corbo M; Rovaris M
    Neurol Sci; 2015 Mar; 36(3):371-7. PubMed ID: 25228014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The two-year progression of structural and functional cerebral MRI in amyotrophic lateral sclerosis.
    Menke RAL; Proudfoot M; Talbot K; Turner MR
    Neuroimage Clin; 2018; 17():953-961. PubMed ID: 29321969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frontotemporal degeneration in amyotrophic lateral sclerosis (ALS): a longitudinal MRI one-year study.
    Trojsi F; Di Nardo F; Siciliano M; Caiazzo G; Femiano C; Passaniti C; Ricciardi D; Russo A; Bisecco A; Esposito S; Monsurrò MR; Cirillo M; Santangelo G; Esposito F; Tedeschi G
    CNS Spectr; 2021 Jun; 26(3):258-267. PubMed ID: 32089134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing brain structural MRI and metabolic FDG-PET changes in patients with ALS-FTD: 'the chicken or the egg?' question.
    Rajagopalan V; Pioro EP
    J Neurol Neurosurg Psychiatry; 2015 Sep; 86(9):952-8. PubMed ID: 25520437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct patterns of cortical atrophy in ALS patients with or without dementia: an MRI VBM study.
    Rajagopalan V; Pioro EP
    Amyotroph Lateral Scler Frontotemporal Degener; 2014 Jun; 15(3-4):216-25. PubMed ID: 24555884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Grey matter correlates of clinical variables in amyotrophic lateral sclerosis (ALS): a neuroimaging study of ALS motor phenotype heterogeneity and cortical focality.
    Bede P; Bokde A; Elamin M; Byrne S; McLaughlin RL; Jordan N; Hampel H; Gallagher L; Lynch C; Fagan AJ; Pender N; Hardiman O
    J Neurol Neurosurg Psychiatry; 2013 Jul; 84(7):766-73. PubMed ID: 23085933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between Clinical Parameters and Brain Structure in Sporadic Amyotrophic Lateral Sclerosis Patients According to Onset Type: A Voxel-Based Morphometric Study.
    Kim HJ; de Leon M; Wang X; Kim HY; Lee YJ; Kim YH; Kim SH
    PLoS One; 2017; 12(1):e0168424. PubMed ID: 28095425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural explanation of poor prognosis of amyotrophic lateral sclerosis in the non-demented state.
    Kim HJ; Oh SI; de Leon M; Wang X; Oh KW; Park JS; Deshpande A; Buj M; Kim SH
    Eur J Neurol; 2017 Jan; 24(1):122-129. PubMed ID: 27753163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microstructural changes across different clinical milestones of disease in amyotrophic lateral sclerosis.
    Trojsi F; Caiazzo G; Corbo D; Piccirillo G; Cristillo V; Femiano C; Ferrantino T; Cirillo M; Monsurrò MR; Esposito F; Tedeschi G
    PLoS One; 2015; 10(3):e0119045. PubMed ID: 25793718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.